Dr. Sanjay Mathew is a leading expert in the psychopharmacological management of adult patients with difficult-to-treat depressive and anxiety disorders and is currently an Associate Professor of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas. Dr. Mathew is the Johnson Family Chair for Research in Psychiatry, Associate Professor with Tenure in the Menninger Department of Psychiatry and Behavioral Sciences, and director of the Mood & Anxiety Disorders Research Program. His research program is the recipient of federal grants and contracts from the National Institute of Mental Health (NIMH) and the Department of Veterans Affairs to develop novel therapies for patients with treatment-resistant depression and post-traumatic stress disorder (PTSD). His translational research program focuses on testing of experimental therapies for depression and anxiety, and discovering illness and treatment-related biomarkers. Dr. Mathew’s group has overseen and collaborated in numerous early-phase investigations of glutamate-modulating agents which act as rapidly-acting antidepressants.